Jingu Lian Pian (金骨莲片)金骨莲片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 河南省新四方制药有限公司Chinese legal name: 河南省新四方制药有限公司
主要成分Active Ingredients
- 透骨香Tougu Xiang
- 汉桃叶Hantao Ye
- 大血藤Daxue Teng
- 八角枫Bajiao Feng
- 金铁锁Jintie Suo
药物知识说明
透骨香是一种在国家药监局注册认定的药品。该药品含有八角枫、大血藤、透骨香-4fa6fab1等成分。
该药品关联的活性成分包括：八角枫Bajiao Feng、大血藤Daxue Teng、透骨香Tougu Xiang、金铁锁Jintie Suo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：河南省新四方制药有限公司Chinese legal name: 河南省新四方制药有限公司。
您可以探索含有相同成分的其他药品：八角枫-26f22b40成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 金骨莲片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 八角枫Bajiao Feng, 大血藤Daxue Teng, 透骨香Tougu Xiang, 金铁锁Jintie Suo.
Manufacturers recorded for this product: 河南省新四方制药有限公司Chinese legal name: 河南省新四方制药有限公司.
Explore other medicines containing the same ingredient: 八角枫 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 金骨莲片Recorded Chinese name: 金骨莲片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.24g*24片0.24 g × 24 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 河南省新四方制药有限公司Chinese legal name: 河南省新四方制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20080203
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20080203
Manufacturer
Chinese legal name: 河南省新四方制药有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
0.24 g × 24 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字Z20080203
生产企业
河南省新四方制药有限公司(国产)
功能主治
祛风除湿，消肿止痛。用于风湿痹阻所致的关节肿痛，屈伸不利。
用法用量
口服。一次2片，一日3次；或遵医嘱。
不良反应
个别患者服药后会有食道哽阻，不适之感，或胃肠不适感。
禁忌
儿童、孕妇禁用。
注意事项
1．忌寒凉、辛辣及油腻食物。
2．本品宜饭后服用。
3．不宜在服药期间同时服用其它泻火及滋补性中药。
4．热痹者不适用，主要表现为关节肿痛如灼、痛处发热，疼痛窜痛无定处，口干唇燥。
5．有高血压、心脏病、肝病、糖尿病、肾病等慢性病严重者应在医师指导下服用。
6．服药7天症状无缓解，应去医院就诊。
7．严格按照用法用量服用，年老体弱者应在医师指导下服用。
8．对本品过敏者禁用，过敏体质者慎用。
9．本品性状发生改变时禁止使用。
10．请将本品放在儿童不能接触的地方。
11．如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密闭保存。
规格
0.24g*24片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.